Midazolam Hydrochloride (Midazolam Hydrochloride) (Syrup) 2 mg/mL

Midazolam Hydrochloride Syrup 2 mg/mL is a prescription benzodiazepine used for sedation and anxiety relief. This fast-acting syrup provides short-term relief for medical procedures and pre-surgery anxiety. Always follow healthcare provider guidance when using.

Strength

2 mg/mL

Manufacturer / TM Owner

Paddock Laboratories, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Midazolam Hydrochloride Syrup 2 mg/mL is commonly used to produce sedation before medical procedures or surgeries. It may also be prescribed to relieve severe anxiety or agitation in certain clinical settings. The syrup form allows for precise dosing and easy administration in pediatric and adult patients.

Side Effects

Midazolam Hydrochloride Syrup 2 mg/mL typically induces drowsiness and relaxation within minutes of administration. Users may experience a calming effect and reduced anxiety, making it easier to undergo medical procedures. Effects vary by individual and dose.

Precautions & Warnings

Midazolam Hydrochloride Syrup 2 mg/mL should only be used under direct medical supervision due to its sedative properties. Avoid activities requiring alertness until fully recovered. Inform your healthcare provider about all medications and health conditions before use.

Avoid Interactions

Midazolam Hydrochloride Syrup 2 mg/mL may interact with other central nervous system depressants, including alcohol and opioids. Certain medications, such as CYP3A4 inhibitors, can increase sedation levels. Always disclose all current medications to your healthcare provider.

Frequently Asked Questions

It is used for sedation before medical procedures and to relieve severe anxiety in clinical settings.

Effects typically begin within 10–20 minutes after administration, depending on dose and individual response.

Consult your healthcare provider before combining with other medications, as interactions may occur.

It may be prescribed for pediatric sedation under strict medical supervision and dosing guidelines.

Avoid alcohol, driving, or operating machinery until you know how the medication affects you.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.